Why the study?
Does intravenous pindolol reduce infarct size in a pig model of experimental myocardial infarction?
Does intravenous pindolol reduce infarct size in a pig model of experimental myocardial infarction?
Intravenous pindolol did not significantly reduce infarct size in a pig model of experimental myocardial infarction.
No infarct size reduction with pindolol in pigs; leaves open beta-blocker effects in experimental MI and should not change practice.
The effect of pindolol on experimental myocardial infarction was studied in a pig model. Intravenous application of 0.05 mg pindolol per kg body weight was initiated one hour after coronary ligation and repeated at 12-hour intervals for five days. No significant difference in infarct size could be found between pindolol-treated animals (20.4 +/- 0.6% SEM of whole ventricular mass, n = 6) and untreated controls (20.5 +/- 1.2% SEM, n = 9). Hemodynamic data did not change significantly throughout the experiment. These results differ in part from those reported by other investigators: The disagreement may be due to the specific pharmacological properties of the applied drug, to variations in the dosages of beta blockers, as well as to differences in the study design.
No takes yet. Share an insight, caveat, or question.
Friedli et al. (1986) studied this question.